Portfolio News
Sofinnova Capital
Nucana plc announces pricing of initial public offering
Nucana plc announces pricing of initial public offering
Related News
Elevara Medicines Doses First Patient in Phase 2b START-SYNERGY Trial of ELV001 in Rheumatoid Arthritis Patients with Incomplete Response to TNFi
May Health Raises $11.7M to Advance its Novel Technology to Treat PCOS-related Infertility
Adapt or Go Extinct: Novameat Unveils the Ingredient That Will Save the Global Meat Crisis
Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
Verley secures $38 million Series A to commercialize high-performance whey protein ingredients through precision fermentation